Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine for Prevention of Perinatal HBV Transmission
NCT00939068Phase 4Unknown
- Sponsor
- Southeast University
- Start
- Feb 2008
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of telbivudine in hepatitis B (HBV), sponsored by Southeast University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00939068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939068.